- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba prepares jump to 64 slices
The Aquilion family of multislice CT scanners will soon include a system capable of generating 64 slices per rotation. The company formally announced at the International Symposium on Multidetector-Row CT that it will release a 64-slice version of its
The Aquilion family of multislice CT scanners will soon include a system capable of generating 64 slices per rotation. The company formally announced at the International Symposium on Multidetector-Row CT that it will release a 64-slice version of its Aquilion CT next year. The announcement followed a presentation at the June symposium by Toshiba luminary Dr. Kazuhiro Katada, who described his experience with a version of the scanner installed in March at Fujita Health University in Japan. The first images were shown publicly at the Japanese Radiology Congress in April (SCAN 6/2/04). Aquilion 64 is built on the same platform as the Aquilion 32, using Toshiba's 64-row Quantum detector. The 64-slice configuration will be available for routine delivery next year, according to the company. Aquilion 32, which will enter commercial production late this year, will be field-upgradable to a 64-slice configuration with the addition of supplementary data channels.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
